Intravenous immunoglobulin in MS: promise or failure?

@article{Fazekas2007IntravenousII,
  title={Intravenous immunoglobulin in MS: promise or failure?},
  author={Franz Fazekas and Siegrid Strasser-Fuchs and Otto Roelf Hommes},
  journal={Journal of the neurological sciences},
  year={2007},
  volume={259 1-2},
  pages={61-6}
}
There is an established role for intravenous immunoglobulin (IVIG) in the treatment of certain neurologic autoimmune disorders which affect the peripheral nervous system and a variety of immunomodulatory properties of IVIG have been proposed. This prompted an intense research into the efficacy of IVIG in central nervous system autoimmune disorders and until now several well-controlled clinical trials have been performed in different stages and phenotypes of multiple sclerosis (MS). The results… CONTINUE READING
8 Citations
0 References
Similar Papers